Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, Boehringer Ingelheim, Amgen Inc., Pfizer Inc., Device Platform Developers and Design Houses, Ypsomed AG (UnoPen, YpsoMate, ServoPen, SmartPilot), SHL Medical, Owen Mumford (Aidaptus, Autoject) and Others
Improved gut comfort in patients with GI issues
This increase is believed to reflect the bodys natural hormone production recovering as weight and insulin resistance improve
Table after table in the record, they noted, showed Lilly and Novo filling every wholesaler order and still sitting on millions of extra doses
The medication reduces appetite and helps regulate blood sugar